O. Baud et al., Antenatal glucocorticoid treatment and cystic periventricular leukomalaciain very premature infants, N ENG J MED, 341(16), 1999, pp. 1190-1196
Citations number
20
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Background Antenatal glucocorticoid therapy decreases the incidence of seve
ral complications among very premature infants. However, its effect on the
occurrence of cystic periventricular leukomalacia, a major cause of cerebra
l palsy, remains unknown.
Methods We retrospectively analyzed a cohort of 883 live-born infants, with
gestational ages ranging from 24 to 31 weeks, who were born between Januar
y 1993 and December 1996 at three perinatal centers in the Paris area. The
mothers of 361 infants had received betamethasone before delivery, the moth
ers of 165 infants had received dexamethasone before delivery, and the moth
ers of 357 infants did not receive glucocorticoids. We compared the rates o
f cystic periventricular leukomalacia among the three groups of infants in
bivariate and multivariate analyses after adjustment for confounding factor
s.
Results The rate of cystic periventricular leukomalacia was 4.4 percent amo
ng the infants whose mothers had received betamethasone, 11.0 percent among
the infants whose mothers had received dexamethasone, and 8.4 percent amon
g the infants whose mothers had not received a glucocorticoid. After adjust
ment for gestational age, the mode of delivery, and the presence or absence
of chorioamnionitis, prolonged interval between the rupture of membranes a
nd delivery (>24 hours), preeclampsia, and the use of tocolytic drugs, ante
natal exposure to betamethasone was associated with a lower risk of cystic
periventricular leukomalacia than was either the absence of glucocorticoid
therapy (adjusted odds ratio, 0.5; 95 percent confidence interval, 0.2 to 0
.9) or exposure to dexamethasone (adjusted odds ratio, 0.3; 95 percent conf
idence interval, 0.1 to 0.7). The adjusted odds ratio for the group of infa
nts whose mothers had received dexamethasone as compared with the group of
infants whose mothers had not received a glucocorticoid was 1.5 (95 percent
confidence interval, 0.8 to 2.9).
Conclusions Antenatal exposure to betamethasone but not dexamethasone is as
sociated with a decreased risk of cystic periventricular leukomalacia among
very premature infants. (N Engl J Med 1999;341:1190-6.) (C)1999, Massachus
etts Medical Society.